Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations

Area of Science:

• Neuropharmacology
• Dopamine Receptor Research

Background:

• Reviewed pharmacological actions of dopamine analogue enantiomers, 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP).
• Described action profiles of transdihydrolisuride (TDHL) and 7-OH-1,2,3,4,4a,5,6,10-octahydrobenzo(f)quinoline (HW 165).
• Noted that (-)-3-PPP, TDHL, and HW 165 affect dopamine (DA) receptors variably based on location and conditions.

Purpose of the Study:

• To investigate the influence of DA receptor responsiveness and prior agonist occupancy on the intrinsic activity of DA analogues.
• To explore the role of endogenous dopamine competition in the partial agonist activity of these agents.
• To discuss theoretical implications of DA receptor adaptational states and evaluate the behavioral profile and clinical potential of (-)-3-PPP.

Main Methods:

• Theoretical analysis of dopamine receptor pharmacology.
• Review of existing pharmacological and behavioral data for DA receptor ligands.
• Comparison of (-)-3-PPP's behavioral profile with classical DA antagonists.

Main Results:

• Intrinsic activity of DA receptor agents is linked to receptor responsiveness, influenced by prior agonist occupancy.
• Partial agonist activity is modulated by the relative concentrations of the drug and endogenous dopamine.
• DA receptors may exist in various adaptational states affecting drug responses.

Conclusions:

• The action of DA receptor ligands is complex, influenced by receptor state and endogenous neurotransmitter levels.
• (-)-3-PPP exhibits a distinct behavioral profile with potential clinical applications.
• Understanding DA receptor adaptational states is crucial for predicting drug efficacy.